Clinical performance indicators: intolerance for variety?

Abhijit Basu1, Rosemary Howell, Deepa Gopinath

  • 1University Hospital of South Manchester, Wythenshawe, UK. babuabhijitbasu@googlemail.com

Insights

Assessing National Health Service (NHS) hospital performance is challenging due to inconsistent clinical indicators. This study suggests using standardized activities for accurate hospital performance measurement.

Area of Science:

  • Healthcare Management
  • Clinical Performance Measurement
  • Hospital Administration

Background:

  • National Health Service (NHS) hospitals face continuous scrutiny regarding performance.
  • Independent bodies recommend clinical indicators for assessing non-financial hospital performance.

Purpose of the Study:

  • To critically analyze the performance of a single UK hospital against recommended clinical indicators.
  • To elucidate the difficulties in measuring clinical performance within the NHS.

Main Methods:

  • Utilized 12 months of data presented to the Hospital Trust Board.
  • Included previous years' data where available for comparative analysis.

Main Results:

  • Hospital performance calculation proved extremely difficult due to complex ratios.
  • Lack of standardization in indicators led to ambiguous interpretations of performance (better, worse, or indifferent).

Conclusions:

  • Direct comparison with other hospitals was precluded due to a lack of similar analyses in existing literature.
  • Highlights the inherent inconsistency in performance indicators, cautioning against reward-rebuke systems.
  • Suggests using standardized, easily controlled activities or internal historical data for more reliable hospital performance measurement.
Abstract

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...